Company / Shareholders' Equity
DNA X, Inc. Shareholders' Equity History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$22.4M
FY2024
5-year range
$18.6M / $25.5M
FY2020-FY2024
Trend
+11.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $19M to $22M over the past 2 years.
Based on SEC 10-K filings.
$22M in FY2024 with a 5-year CAGR of +34.3%.
Improved from $19M to $22M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- +34.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +34.3%, indicating consistent growth.
- In FY2024, shareholders' equity increased 11.6% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $22.4M | +11.6% |
| FY2023 | $20.0M | +7.6% |
| FY2022 | $18.6M | -27.0% |
| FY2021 | $25.5M | +0.0% |
| FY2020 | $25.5M | +397.7% |
| FY2019 | $5.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026